期刊文献+

静注胺碘酮治疗室速、室颤的进展 被引量:1

下载PDF
导出
作者 唐伦先
出处 《华西医学》 CAS 2002年第4期586-587,共2页 West China Medical Journal
  • 相关文献

参考文献29

  • 1[1]Hohnloser SH ,Zebel M,Zehendar M,et a1.Efficacy of intravenously adminiStered amiodarone for short-term control of serious arrhythmiaS.[J].JCardiovasc Pharmacol,1992,20:663-9
  • 2[2]The Medical letter on Drugs and Therapeutics,1995,37:114-5.
  • 3[3]Podrid PJ.Amiodarone:reevaluation of an old drug[J].Ann Intern Med ,1995,122:689-700.
  • 4[4]Chow MS.Intravenous amiodarone: pharmacology, pharmacokinetics, and clinical use[J].Ann Pharmacother,1996,30:637-43.
  • 5[5]Mayuga RD,Singer DH.Effects of intravenous amiodarone on electrical dispersion in normal and ischaemic tissues and on arrhythmia inducibility:monophasic action potential Studies[J].Cardiovascres,1984,55:571-9.
  • 6[6]Zhou L,White CN,Chen BP. A comparison of the antifibrillatory effects of desethylamiodarone to amiodarone in a Swine model [J].J Cardiovasc Pharmacol,1999,34:440-5.
  • 7[7]Kojima S,WU ST,Wikman-coffelt Acute amniodarone terminates ventricular fibrillation bymodifying cellular Ca2+ homeostasis in isolated perfused rat hearts.J,ParmleyWW[J].J Pharmacol Exp Ther,1995,275:254-62.
  • 8[8]DU XJ,Elser MD,Dart AU.sympatholytic action of intravenous amiodarone in the rat heart.[J].Circulation,1995,91:462-70.
  • 9[9]Singn BN,Venkatesh N,Nademanee K,et a1.The historical development ,cellular electrophysiology,and pharmacology of amiodarone[J].Prog Cardiovasc DiS,1989,312;249-80.
  • 10[10]Talajic M,DeRoodeR,Nattel S.Comparative electrophysiologic effects of intravenous amiodarone and desethylamiodarone in dogs:evidence for Clinically relevant activity of the metabolite[J].Circulation,1987,75:265-71.

同被引文献31

  • 1Green JB,Ross JS,Jackevicius CA,et al.When choosing statin therapy:the case for generics[J].JAMA Intern Med,2013,173(3):229.
  • 2Wenger NK,Lewis SJ,Herrington DM,et al.Outcomes of using high-or low-dose atorvastatin in patients 65years of age or older with stable coronary heart disease[J].Ann Intern Med,2007,147(1):1.
  • 3Stone NJ,Robinson JG,Lichtenstein AH,et al.2013ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk inadults:a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines[J].JAm Coll Cardiol,2014,63(25B):2 889.
  • 4Percha B,Altman RB.Informatics confronts drug-drug interactions[J].Trends Pharmacol Sci,2013,34(3):178.
  • 5Tantry US,Jeong YH,Gurbel PA.The clopidogrel-statin interaction[J].Circ J,2014,78(3):592.
  • 6Bhindi R,Ormerod O,Newton J,et al.Interaction between statins and clopidogrel:is there anything clinically relevant?[J].QJM,2008,101(12):915.
  • 7Piorkowski M,Weikert U,Schwimmbeck PL,et al.ADPinduced platelet degranulation in healthy individuals is reduced by clopidogrel after pretreatment with atorvastatin[J].Thromb Haemost,2004,92(3):614.
  • 8Lau WC,Waskell LA,Watkins PB,et al.Atorvastatin reduces the ability of clopidogrel to inhibit platelet aggregation:a new drug-drug interaction[J].Circulation,2003,107(1):32.
  • 9Saw J,Brennan DM,Steinhubl SR,et al.Lack of evidence of a clopidogrel-statin interaction in the CHARISMAtrial[J].J Am Coll Cardiol,2007,50(4):291.
  • 10Heintjes EM,Penning-van Beest FJ,Johansson S,et al.Comparison of incidences of cardiovascular events among new users of different statins:a retrospective observational cohort study[J].Curr Med Res Opin,2009,25(11):2 621.

引证文献1

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部